SELPLG and acute myeloid leukemia: Although both cohorts were transplanted with the same number (30,000 BM KIT+GFP+) AML blasts each, there was a marked 3.5-fold (p < 0.0001) increase in median disease-free survival in recipient mice of Selplg–/– AML compared to recipients of WT AML (Figure 4B).